SCHEMBL5042586

SCHEMBL5042586

CO[C@H](C(=O)NCc1ccc(C#N)cc1)c1cccc(OC(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.52
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
LMNA P02545 4/20 0.41
ACACB O00763 1/20 0.41
ROS1 P08922 1/20 0.41
ALK Q9UM73 1/20 0.41
DGAT2 Q96PD7 1/20 0.41
SCN2A Q99250 1/20 0.41
SCN10A Q9Y5Y9 1/20 0.41
RECQL P46063 1/20 0.40
ELANE P08246 1/20 0.40
SMPD1 P17405 1/20 0.39
EPHX2 P34913 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5042585 1.00 PKM (0.52) PKMRAB9ANPC1SLC1A3SLC1A2
SCHEMBL5041641 0.88 PKM (0.57) PKMSLC1A3SLC1A2LMNAKMT2A
SCHEMBL5041644 0.88 PKM (0.57) PKMSLC1A3SLC1A2LMNAKMT2A
SCHEMBL5041972 0.88 PKM (0.52) PKMRAB9ANPC1SLC1A3SLC1A2
SCHEMBL5041978 0.88 PKM (0.52) PKMRAB9ANPC1SLC1A3SLC1A2
SCHEMBL5043284 0.86 PKM (0.54) PKMSLC1A3SLC1A2LMNAACACB
SCHEMBL5043288 0.86 PKM (0.54) PKMSLC1A3SLC1A2LMNAACACB
SCHEMBL5038176 0.86 PKM (0.55) PKMRAB9ASLC1A3SLC1A2LMNA
SCHEMBL5038178 0.86 PKM (0.55) PKMRAB9ASLC1A3SLC1A2LMNA
SCHEMBL5040508 0.84 PKM (0.72) PKMSLC1A3SLC1A2LMNARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PKM 4225/4885RAB9A 124/4885NPC1 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.